Possible Therapeutic Effect of Trilostane (cas 13647-35-3) in Rodent Models of Inflammation and Nociception
-
Add time:09/08/2019 Source:sciencedirect.com
BackgroundTrilostane (cas 13647-35-3) was identified in an in vivo screen of compounds in a lipopolysaccharide model of inflammation to support a repurposing effort. There is no previous documentation of any anti-inflammatory effects of trilostane.
We also recommend Trading Suppliers and Manufacturers of Trilostane (cas 13647-35-3). Pls Click Website Link as below: cas 13647-35-3 suppliers
Prev:Trilostane (cas 13647-35-3)☆
Next:Short CommunicationExpression of 11β-hydroxysteroid dehydrogenase isoforms in canine adrenal glands treated with Trilostane (cas 13647-35-3)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- The antidepressant-like effects of the 3β-hydroxysteroid dehydrogenase inhibitor Trilostane (cas 13647-35-3) in mice is related to changes in neuroactive steroid and monoamine levels09/24/2019
- Topical reviewMedical Management of Pituitary-Dependent Hyperadrenocorticism: Mitotane versus Trilostane (cas 13647-35-3)09/10/2019
- Short CommunicationExpression of 11β-hydroxysteroid dehydrogenase isoforms in canine adrenal glands treated with Trilostane (cas 13647-35-3)09/09/2019
- Trilostane (cas 13647-35-3)☆09/07/2019
- Short CommunicationStability of compounded Trilostane (cas 13647-35-3) suspension in cod liver oil09/06/2019
- Original ArticleIncidence and risk factors for hypoadrenocorticism in dogs treated with Trilostane (cas 13647-35-3)09/05/2019